These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

205 related items for PubMed ID: 2418176

  • 1. The kallikrein-kinin system as mediator in vasogenic brain edema. Part 3: Inhibition of the kallikrein-kinin system in traumatic brain swelling.
    Unterberg A, Dautermann C, Baethmann A, Müller-Esterl W.
    J Neurosurg; 1986 Feb; 64(2):269-76. PubMed ID: 2418176
    [Abstract] [Full Text] [Related]

  • 2. The kallikrein-kinin system as mediator in vasogenic brain edema. Part 2: Studies on kinin formation in focal and perifocal brain tissue.
    Maier-Hauff K, Baethmann AJ, Lange M, Schürer L, Unterberg A.
    J Neurosurg; 1984 Jul; 61(1):97-106. PubMed ID: 6563063
    [Abstract] [Full Text] [Related]

  • 3. Evidence against leukotrienes as mediators of brain edema.
    Unterberg A, Schmidt W, Wahl M, Ellis EF, Marmarou A, Baethmann A.
    J Neurosurg; 1991 May; 74(5):773-80. PubMed ID: 2013778
    [Abstract] [Full Text] [Related]

  • 4. The kallikrein-kinin system as mediator in vasogenic brain edema. Part 1: Cerebral exposure to bradykinin and plasma.
    Unterberg A, Baethmann AJ.
    J Neurosurg; 1984 Jul; 61(1):87-96. PubMed ID: 6563062
    [Abstract] [Full Text] [Related]

  • 5. LF16-0687 a novel non-peptide bradykinin B2 receptor antagonist reduces vasogenic brain edema from a focal lesion in rats.
    Schulz J, Plesnila N, Eriskat J, Stoffel M, Pruneau D, Baethmann A.
    Acta Neurochir Suppl; 2000 Jul; 76():137-9. PubMed ID: 11449993
    [Abstract] [Full Text] [Related]

  • 6. Treatment of vasogenic brain edema with the novel Cl- transport inhibitor torasemide.
    Staub F, Stoffel M, Berger S, Eriskat J, Baethmann A.
    J Neurotrauma; 1994 Dec; 11(6):679-90. PubMed ID: 7723067
    [Abstract] [Full Text] [Related]

  • 7. Ischemic stroke and traumatic brain injury: the role of the kallikrein-kinin system.
    Albert-Weißenberger C, Sirén AL, Kleinschnitz C.
    Prog Neurobiol; 2013 Dec; 101-102():65-82. PubMed ID: 23274649
    [Abstract] [Full Text] [Related]

  • 8. Significant reduction in brain swelling by administration of nonpeptide kinin B2 receptor antagonist LF 16-0687Ms after controlled cortical impact injury in rats.
    Stover JF, Dohse NK, Unterberg AW.
    J Neurosurg; 2000 May; 92(5):853-9. PubMed ID: 10794301
    [Abstract] [Full Text] [Related]

  • 9. Mediators of brain edema and secondary brain damage.
    Baethmann A, Maier-Hauff K, Kempski O, Unterberg A, Wahl M, Schürer L.
    Crit Care Med; 1988 Oct; 16(10):972-8. PubMed ID: 2901938
    [Abstract] [Full Text] [Related]

  • 10. Role of leukotrienes as mediator compounds in brain edema.
    Unterberg A, Schmidt W, Wahl M, Baethmann A.
    Adv Neurol; 1990 Oct; 52():211-4. PubMed ID: 2118715
    [Abstract] [Full Text] [Related]

  • 11. Release of glutamate and of free fatty acids in vasogenic brain edema.
    Baethmann A, Maier-Hauff K, Schürer L, Lange M, Guggenbichler C, Vogt W, Jacob K, Kempski O.
    J Neurosurg; 1989 Apr; 70(4):578-91. PubMed ID: 2564431
    [Abstract] [Full Text] [Related]

  • 12. [Studies on the involvement of bradykinin in the formation of ischemic brain edema].
    Kamiya T.
    Nihon Ika Daigaku Zasshi; 1990 Apr; 57(2):180-91. PubMed ID: 1694863
    [Abstract] [Full Text] [Related]

  • 13. Effects of early and late intravenous norepinephrine infusion on cerebral perfusion, microcirculation, brain-tissue oxygenation, and edema formation in brain-injured rats.
    Kroppenstedt SN, Thomale UW, Griebenow M, Sakowitz OW, Schaser KD, Mayr PS, Unterberg AW, Stover JF.
    Crit Care Med; 2003 Aug; 31(8):2211-21. PubMed ID: 12973182
    [Abstract] [Full Text] [Related]

  • 14. Treatment of traumatic brain edema by multiple doses of mannitol.
    von Berenberg P, Unterberg A, Schneider GH, Lanksch WR.
    Acta Neurochir Suppl (Wien); 1994 Aug; 60():531-3. PubMed ID: 7976640
    [Abstract] [Full Text] [Related]

  • 15. Trauma-induced cell swelling in cultured astrocytes.
    Jayakumar AR, Rao KV, Panickar KS, Moriyama M, Reddy PV, Norenberg MD.
    J Neuropathol Exp Neurol; 2008 May; 67(5):417-27. PubMed ID: 18431255
    [Abstract] [Full Text] [Related]

  • 16. A rationale for the therapeutic action of aprotinin.
    Haberland G, McConn R.
    Fed Proc; 1979 Dec; 38(13):2760-7. PubMed ID: 159836
    [Abstract] [Full Text] [Related]

  • 17. Mannitol Improves Brain Tissue Oxygenation in a Model of Diffuse Traumatic Brain Injury.
    Schilte C, Bouzat P, Millet A, Boucheix P, Pernet-Gallay K, Lemasson B, Barbier EL, Payen JF.
    Crit Care Med; 2015 Oct; 43(10):2212-8. PubMed ID: 26121074
    [Abstract] [Full Text] [Related]

  • 18. The effect of dietary alpha-tocopherol on the experimental vasogenic brain edema.
    Stoffel M, Berger S, Staub F, Eriskat J, Jacob K, Baethmann A.
    J Neurotrauma; 1997 May; 14(5):339-48. PubMed ID: 9199399
    [Abstract] [Full Text] [Related]

  • 19. Mechanisms of cerebral edema in traumatic brain injury: therapeutic developments.
    Donkin JJ, Vink R.
    Curr Opin Neurol; 2010 Jun; 23(3):293-9. PubMed ID: 20168229
    [Abstract] [Full Text] [Related]

  • 20. Role of bradykinin B2 receptors in the formation of vasogenic brain edema in rats.
    Plesnila N, Schulz J, Stoffel M, Eriskat J, Pruneau D, Baethmann A.
    J Neurotrauma; 2001 Oct; 18(10):1049-58. PubMed ID: 11686492
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.